Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Related Articles by Review for PubMed (Select 22516044)

1.

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.

Zarate CA Jr, Brutsche N, Laje G, Luckenbaugh DA, Venkata SL, Ramamoorthy A, Moaddel R, Wainer IW.

Biol Psychiatry. 2012 Aug 15;72(4):331-8. doi: 10.1016/j.biopsych.2012.03.004. Epub 2012 Apr 18.

2.

A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.

Naughton M, Clarke G, O'Leary OF, Cryan JF, Dinan TG.

J Affect Disord. 2014 Mar;156:24-35. doi: 10.1016/j.jad.2013.11.014. Epub 2013 Dec 10. Review.

PMID:
24388038
3.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
4.

[Ketamine for treatment of acute depression].

Hjerrild S, Bjerre J, Pedersen RH, Videbech P.

Ugeskr Laeger. 2013 Sep 9;175(37):2090-3. Review. Danish.

PMID:
24011203
5.

Intravenous ketamine for treatment-resistant major depressive disorder.

Covvey JR, Crawford AN, Lowe DK.

Ann Pharmacother. 2012 Jan;46(1):117-23. doi: 10.1345/aph.1Q371. Epub 2011 Dec 20. Review.

PMID:
22190250
6.

"Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder.

Ghaemi SN, Ko JY, Goodwin FK.

Can J Psychiatry. 2002 Mar;47(2):125-34. Review.

PMID:
11926074
7.

Ketamine as an alternative treatment for treatment-resistant depression.

Dowben JS, Grant JS, Keltner NL.

Perspect Psychiatr Care. 2013 Jan;49(1):2-4. doi: 10.1111/ppc.12006. Epub 2012 Dec 30. Review. No abstract available.

PMID:
23293991
8.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
9.

Personalized medicine in major depressive disorder -- opportunities and pitfalls.

Miller DB, O'Callaghan JP.

Metabolism. 2013 Jan;62 Suppl 1:S34-9. doi: 10.1016/j.metabol.2012.08.021. Epub 2012 Sep 26. Review.

PMID:
23021040
10.

Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.

Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH.

J Clin Psychiatry. 2013 Nov;74(11):1101-7. doi: 10.4088/JCP.13r08560. Review.

PMID:
24330897
11.

Ketamine for depression: where do we go from here?

Aan Het Rot M, Zarate CA Jr, Charney DS, Mathew SJ.

Biol Psychiatry. 2012 Oct 1;72(7):537-47. doi: 10.1016/j.biopsych.2012.05.003. Epub 2012 Jun 16. Review.

12.

Current status of ketamine and related compounds for depression.

Mathews DC, Zarate CA Jr.

J Clin Psychiatry. 2013 May;74(5):516-7. doi: 10.4088/JCP.13ac08382. Review. No abstract available.

13.

Multistage drug effects of ketamine in the treatment of major depression.

Walter M, Li S, Demenescu LR.

Eur Arch Psychiatry Clin Neurosci. 2014 Nov;264 Suppl 1:S55-65. doi: 10.1007/s00406-014-0535-3. Epub 2014 Sep 13. Review.

PMID:
25217177
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk